Ascendis Pharma

$107.97 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Ascendis Pharma

ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.

Stock Analysis

last close $111.14
1-mo return -17.3%
3-mo return -23.4%
avg daily vol. 217.94T
52-week high 178.71
52-week low 109.36
market cap. $7.0B
forward pe -
annual div. -
roe -42.8%
ltg forecast -
dividend yield -
annual rev. $25M
inst own. -
baraka

Subscribe now for daily local and international financial news

Subscribe